In search of target molecules potentially having an impact on melanoma cells, we came across the cholesterol-binding membrane protein CD133, a widely used marker for stem cells and cancer-initiating cells [5–8] (reviewed in Refs [9–11]). The gene discussed is PROM1; the disease is melanoma.